Sunshine Biopharma Inc.
For the period ended Dec 31, 2024. Filed Apr 1, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Apr 1, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 14. Principal Accounting Fees and Services
ITEM 14. PRINCIPAL ACCOUNTANT FEES AND SERVICES
Our financial statements for the fiscal years ended December 31, 2023 and 2022, were audited by BF Borgers CPA, PC (“Borgers”). On May 3, 2024, the SEC announced that it had settled charges against Borgers that it failed to conduct audits in accordance with the standards of the PCAOB. As part of the settlement, Borgers agreed to a permanent ban on appearing or practicing before the SEC. As a result of Borgers’ settlement with the SEC, we dismissed Borgers as our independent accountant on May 3, 2024.
On May 7, 2024, we retained Bush & Associates CPA LLC (“Bush & Associates”), as our independent registered public accounting firm.
The following table presents fees for professional services rendered by Bush & Associates and Borgers during:
| Fiscal Years Ended December 31, | 2024 | 2023 |
|---|---|---|
| Audit Fees – Bush & Associates | $165,000 | $162,500 |
| Audit Fees – Borgers | – | 170,000 |
| Audit-related fees – Bush & Associates | – | – |
| Audit-related fees – Borgers | – | – |
| Tax Fees – Bush & Associates | – | – |
| Tax Fees – Borgers | – | – |
| All Other Fees | – | – |
| Total – Bush & Associates | $165,000 | $162,500 |
| Total – Borgers | $– | $170,000 |
Audit Fees. Audit fees consist of amounts billed for professional services rendered for the audit of our annual financial statements included in our Annual Reports on Forms 10-K for our fiscal years ended December 31, 2024 and 2023 and for reviews of our interim financial statements included in our Quarterly Reports on Form 10-Q.
**Audit-related Fees.**Audit-related fees represent fees for assurance and related services performed that are reasonably related to the performance of the audit or review of our financial statements.
Tax Fees. Bush & Associates CPA and Borgers did not perform any tax compliance services for us during the years ended December 31, 2024 or 2023.
All Other Fees. Bush & Associates CPA and Borgers did not receive any other fees from us for the years ended December 31, 2024 or 2023.
As of December 31, 2024, the Board of Directors appointed our three independent directors as the members of our audit committee. Our audit committee charter is available is available on our website at www.sunshinebiopharma.com.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.